606 related articles for article (PubMed ID: 30642385)
1. Exosomal miR-196a derived from cancer-associated fibroblasts confers cisplatin resistance in head and neck cancer through targeting CDKN1B and ING5.
Qin X; Guo H; Wang X; Zhu X; Yan M; Wang X; Xu Q; Shi J; Lu E; Chen W; Zhang J
Genome Biol; 2019 Jan; 20(1):12. PubMed ID: 30642385
[TBL] [Abstract][Full Text] [Related]
2. Loss of exosomal miR-3188 in cancer-associated fibroblasts contributes to HNC progression.
Wang X; Qin X; Yan M; Shi J; Xu Q; Li Z; Yang W; Zhang J; Chen W
J Exp Clin Cancer Res; 2019 Apr; 38(1):151. PubMed ID: 30961650
[TBL] [Abstract][Full Text] [Related]
3. CAF secreted miR-522 suppresses ferroptosis and promotes acquired chemo-resistance in gastric cancer.
Zhang H; Deng T; Liu R; Ning T; Yang H; Liu D; Zhang Q; Lin D; Ge S; Bai M; Wang X; Zhang L; Li H; Yang Y; Ji Z; Wang H; Ying G; Ba Y
Mol Cancer; 2020 Feb; 19(1):43. PubMed ID: 32106859
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts secreted miR-103a-3p suppresses apoptosis and promotes cisplatin resistance in non-small cell lung cancer.
Wang H; Huang H; Wang L; Liu Y; Wang M; Zhao S; Lu G; Kang X
Aging (Albany NY); 2021 May; 13(10):14456-14468. PubMed ID: 33999859
[TBL] [Abstract][Full Text] [Related]
5. CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging.
Zhang T; Zhang P; Li HX
Int J Nanomedicine; 2021; 16():561-577. PubMed ID: 33542625
[TBL] [Abstract][Full Text] [Related]
6. Exosomal LINC00355 derived from cancer-associated fibroblasts promotes bladder cancer cell resistance to cisplatin by regulating miR-34b-5p/ABCB1 axis.
Luo G; Zhang Y; Wu Z; Zhang L; Liang C; Chen X
Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):558-566. PubMed ID: 33720323
[TBL] [Abstract][Full Text] [Related]
7. Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28.
Chen B; Sang Y; Song X; Zhang D; Wang L; Zhao W; Liang Y; Zhang N; Yang Q
Theranostics; 2021; 11(8):3932-3947. PubMed ID: 33664871
[TBL] [Abstract][Full Text] [Related]
8. Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1/JAK2/STAT3 signaling pathway.
Zhou X; Yan T; Huang C; Xu Z; Wang L; Jiang E; Wang H; Chen Y; Liu K; Shao Z; Shang Z
J Exp Clin Cancer Res; 2018 Oct; 37(1):242. PubMed ID: 30285793
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis.
Zhang HW; Shi Y; Liu JB; Wang HM; Wang PY; Wu ZJ; Li L; Gu LP; Cao PS; Wang GR; Ma YS; Fu D
J Cell Mol Med; 2021 Apr; 25(8):3699-3713. PubMed ID: 33621425
[TBL] [Abstract][Full Text] [Related]
10. Loss of exosomal miR-320a from cancer-associated fibroblasts contributes to HCC proliferation and metastasis.
Zhang Z; Li X; Sun W; Yue S; Yang J; Li J; Ma B; Wang J; Yang X; Pu M; Ruan B; Zhao G; Huang Q; Wang L; Tao K; Dou K
Cancer Lett; 2017 Jul; 397():33-42. PubMed ID: 28288874
[TBL] [Abstract][Full Text] [Related]
11. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression profiles and bioinformatic analysis of CAF-derived exosomal miRNAs from three moderately differentiated supraglottic LSCC patients.
Wu C; Wang M; Huang Q; Guo Y; Gong H; Hu C; Zhou L
J Clin Lab Anal; 2022 Jan; 36(1):e24108. PubMed ID: 34788477
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts induce monocytic myeloid-derived suppressor cell generation via IL-6/exosomal miR-21-activated STAT3 signaling to promote cisplatin resistance in esophageal squamous cell carcinoma.
Zhao Q; Huang L; Qin G; Qiao Y; Ren F; Shen C; Wang S; Liu S; Lian J; Wang D; Yu W; Zhang Y
Cancer Lett; 2021 Oct; 518():35-48. PubMed ID: 34139285
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin-resistant NSCLC cells induced by hypoxia transmit resistance to sensitive cells through exosomal PKM2.
Wang D; Zhao C; Xu F; Zhang A; Jin M; Zhang K; Liu L; Hua Q; Zhao J; Liu J; Yang H; Huang G
Theranostics; 2021; 11(6):2860-2875. PubMed ID: 33456577
[TBL] [Abstract][Full Text] [Related]
15. Aberrant expression miR-196a is associated with abnormal apoptosis, invasion, and proliferation of pancreatic cancer cells.
Liu M; Du Y; Gao J; Liu J; Kong X; Gong Y; Li Z; Wu H; Chen H
Pancreas; 2013 Oct; 42(7):1169-81. PubMed ID: 24048456
[TBL] [Abstract][Full Text] [Related]
16. Exosomal miR-196a-5p enhances radioresistance in lung cancer cells by downregulating NFKBIA.
Yao F; Shi W; Fang F; Lv MY; Xu M; Wu SY; Huang CL
Kaohsiung J Med Sci; 2023 Jun; 39(6):554-564. PubMed ID: 36912495
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer.
Li Z; Tao Y; Wang X; Jiang P; Li J; Peng M; Zhang X; Chen K; Liu H; Zhen P; Zhu J; Liu X; Liu X
Cell Physiol Biochem; 2018; 51(2):610-629. PubMed ID: 30458449
[TBL] [Abstract][Full Text] [Related]
18. Exosomal transfer of miR-124 inhibits normal fibroblasts to cancer-associated fibroblasts transition by targeting sphingosine kinase 1 in ovarian cancer.
Zhang Y; Cai H; Chen S; Sun D; Zhang D; He Y
J Cell Biochem; 2019 Aug; 120(8):13187-13201. PubMed ID: 30957275
[TBL] [Abstract][Full Text] [Related]
19. Exosomal miRNA-139 in cancer-associated fibroblasts inhibits gastric cancer progression by repressing MMP11 expression.
Xu G; Zhang B; Ye J; Cao S; Shi J; Zhao Y; Wang Y; Sang J; Yao Y; Guan W; Tao J; Feng M; Zhang W
Int J Biol Sci; 2019; 15(11):2320-2329. PubMed ID: 31595150
[TBL] [Abstract][Full Text] [Related]
20. Cancer-associated fibroblasts activated by miR-196a promote the migration and invasion of lung cancer cells.
Lee S; Hong JH; Kim JS; Yoon JS; Chun SH; Hong SA; Kim EJ; Kang K; Lee Kang J; Ko YH; Ahn YH
Cancer Lett; 2021 Jun; 508():92-103. PubMed ID: 33775710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
